We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Qualcomm
QCOM
$185B
| $172M | 0.53% |
3,123,530
+802,114
| +35% | +$44.8M |
|
52
State Street SPDR S&P 500 ETF Trust
SPY
$787B
| $161M | 0.49% |
664,083
-2,539
| -0.4% | -$608K |
|
53
PepsiCo
PEP
$186B
| $160M | 0.49% |
1,387,029
+352,511
| +34% | +$40.4M |
|
54
Ameriprise Financial
AMP
$47.5B
| $159M | 0.49% |
1,246,504
-29,486
| -2% | -$3.74M |
|
55
RTX Corp
RTX
$263B
| $155M | 0.48% |
2,022,780
+217,156
| +12% | +$16.3M |
|
56
Merck
MRK
$316B
| $152M | 0.46% |
2,482,770
+316,247
| +15% | +$19.3M |
|
|
ESRX
57
DELISTED
Express Scripts Holding Company
ESRX
| $150M | 0.46% |
2,350,711
+520,119
| +28% | +$32.7M |
|
58
Bank of America
BAC
$432B
| $149M | 0.45% |
6,133,954
+1,692,718
| +38% | +$39.5M |
|
59
Regions Financial
RF
$26.3B
| $147M | 0.45% |
10,022,103
+3,091,886
| +45% | +$43.5M |
|
|
HBI
60
DELISTED
Hanesbrands
HBI
| $132M | 0.4% |
5,694,667
-119,394
| -2% | -$2.58M |
|
61
UnitedHealth
UNH
$395B
| $128M | 0.39% |
690,886
+25,710
| +4% | +$4.51M |
|
62
Occidental Petroleum
OXY
$57.1B
| $127M | 0.39% |
2,118,685
+527,431
| +33% | +$32.3M |
|
|
AABA
63
DELISTED
Altaba Inc
AABA
| $126M | 0.38% |
+2,311,186
| New | +$126M |
|
|
WCN
64
Waste Connections
WCN
$42.7B
| $122M | 0.37% |
1,893,233
-17,764
| -0.9% | -$1.1M |
|
65
Crown Castle
CCI
$33.8B
| $122M | 0.37% |
1,216,890
+247,445
| +26% | +$24.3M |
|
66
T. Rowe Price
TROW
$24.9B
| $122M | 0.37% |
1,640,823
+160,219
| +11% | +$11.5M |
|
|
DD
67
DELISTED
Du Pont De Nemours E I
DD
| $121M | 0.37% |
1,495,480
+6,814
| +0.5% | +$545K |
|
68
GE Aerospace
GE
$356B
| $108M | 0.33% |
837,626
-30,342
| -3% | -$4.16M |
|
|
AET
69
DELISTED
Aetna Inc
AET
| $108M | 0.33% |
709,390
-26,696
| -4% | -$3.77M |
|
70
Teva Pharmaceuticals
TEVA
$35.4B
| $102M | 0.31% |
3,081,678
+514,280
| +20% | +$15.9M |
|
71
Best Buy
BBY
$18.3B
| $101M | 0.31% |
1,762,527
+1,372,411
| +352% | +$73.3M |
|
72
General Dynamics
GD
$101B
| $100M | 0.31% |
506,474
-17,607
| -3% | -$3.45M |
|
73
Broadridge
BR
$16.6B
| $98.2M | 0.3% |
1,299,758
-26,773
| -2% | -$1.93M |
|
74
Idexx Laboratories
IDXX
$43.2B
| $97.6M | 0.3% |
604,559
+163,547
| +37% | +$26.6M |
|
75
Albany International
AIN
$2.12B
| $94.7M | 0.29% |
1,773,458
+6,377
| +0.4% | +$309K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.